Cytarabine: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Howard C. Berkowitz
(New page: {{subpages}} '''Cytaribine''' is a a pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. It is an antimetabo...)
 
imported>Robert Badgett
(Added mesh references and czmed)
Line 1: Line 1:
{{subpages}}
{{subpages}}
'''Cytaribine''' is a a [[pyrimidine]] nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic [[leukemia]]. It is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties.
'''Cytaribine''' is a a [[pyrimidine]] nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic [[leukemia]]. It is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties.<ref>{{MeSH}}</ref>
 
==References==
<references/>
 
==External links
{{CZMed}}

Revision as of 18:41, 1 March 2009

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Cytaribine is a a pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. It is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties.[1]

References

==External links The most up-to-date information about Cytarabine and other drugs can be found at the following sites.